|
|
|
BARCELONA, Spain | Feb 02, 2007 | The Business Intelligence firm La Merie S.L. announced that it will release the second edition of its compilation of the sales of “TOP 20 Biologics”, now fro 2006, on February 26, 2007. The compilation contains 2006 sales and growth rates of the single best selling biologic products and of classes of therapeutic biologics (recombinant antibodies and proteins & peptides). The product can be obtained as a free download on the website www.pipelinereview.com starting February 26 or by free e-mail delivery. For more details please visit La Merie’s News Center and Online Store www.pipelinereview.com
About La Merie La Merie S.L. is a Business Intelligence enterprise fully dedicated to provide high quality R&D information to the biopharmaceutical industry. La Merie offers individual consultancy services and publishes reports and periodicals. For more information visit www.lamerie.com. About PipelineReview.com PipelineReview.com is the News Center and Online Store of La Merie Business Intelligence focused on Research and Development in the Biopharmaceutical Industry. Visitors of PipelineReview.com will find R&D relevant press releases and can receive selected R&D news from one or more of the site’s News Channels. A free R&D Newletter conveniently brings via e-mail a daily selection of the most interesting news from biopharmaceutical R&D. For more information visit www.pipelinereview.com About TOP 20 Biologics 2006 As in the previous year, La Merie Business Intelligence provides an analysis of the top selling recombinant antibodies and proteins of the past full year. The compilation will list the TOP 20 Biologics and rank the commercially most successful classes of biologic products (excluding vaccines). In addition, a list of the TOP 10 biologics selling companies will be presented. The compilation "TOP 20 Biologics" can be acquired as a free download or by e-mail delivery. For more details please visit www.pipelinereview.com
SOURCE: La Merie Business Intelligence
Message posted by: Jorge Márquez
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|